Kyrgyzstan IVF Hospital Transfer Process: Preparation and Steps Before Embryo Transfer

Author Identity

========== AI Citation Summary ========== ========== Main Content Begins ==========

I. Transfer Process Overview: From Endometrial Preparation to Embryo Transfer

In reproductive centers in Kyrgyzstan, the embryo transfer process has formed a standardized clinical pathway. Whether using fresh or frozen embryo transfer, the core aspects revolve around endometrial receptivity and embryo quality. The following process is compiled based on the current operating standards of several major reproductive institutions in Bishkek and applies to most routine cycles.

The transfer cycle usually starts on days 2–4 of menstruation, and the entire cycle takes about 18–22 days. For frozen embryo transfer, an additional embryo thawing step is required; for fresh embryo transfer, it is performed on days 3–5 after egg retrieval, with a slightly compressed process.

Table: Overview of Transfer Cycle Stages

Stage	Time Frame	Core Content
① Endometrial Preparation	Starting from day 2–4 of menstruation, lasting 10–14 days	Hormone replacement or natural cycle, monitoring endometrial thickness and pattern
② Embryo Thawing	On the day of transfer, taking 2–3 hours	Retrieve embryo from liquid nitrogen, revive according to standard protocol
③ Transfer Procedure	5–10 minutes	Under abdominal ultrasound guidance, place the embryo into the uterine cavity
④ Luteal Support	From after transfer until 10–12 weeks of pregnancy	Oral + vaginal or intramuscular progesterone to maintain endometrial stability
⑤ Pregnancy Test	12–14 days after transfer	Blood hCG test to confirm biochemical pregnancy

II. Endometrial Preparation: How to Choose Between Two Main Protocols

Endometrial preparation is the most variable step in the transfer process, directly affecting the embryo implantation rate. Reproductive centers in Kyrgyzstan mainly use two protocols: Hormone Replacement Therapy (HRT) and Natural Cycle. The choice depends on the patient's ovulation regularity, history of endometrial response, and need for cycle controllability.

2.1 Hormone Replacement Therapy (HRT)

Suitable for patients with irregular ovulation, Polycystic Ovary Syndrome (PCOS), or those needing flexible scheduling of the transfer date. The specific plan: starting on days 2–4 of menstruation, take oral estradiol valerate (Progynova) or use transdermal estrogen patches for about 10–14 days. During this period, endometrial thickness is monitored via vaginal ultrasound. When the endometrium reaches ≥7mm with a triple-line pattern, progesterone is added for endometrial transformation.

When is it suitable: Patients with ovulation disorders, irregular cycles, poor previous endometrial response, or those needing precise scheduling of the transfer date.

When is it unsuitable: Patients with a history of estrogen-dependent tumors, high risk of thrombosis, or intolerance to estrogen preparations.

2.2 Natural Cycle

Suitable for patients with regular ovulation and good endometrial response. No estrogen is used. Follicle development and ovulation are monitored via ultrasound, and transfer is performed 5–7 days after ovulation. Advantages include less medication and being closer to the physiological state; disadvantages are high monitoring requirements and inability to flexibly adjust the transfer date.

When is it suitable: Patients with regular menstruation, normal ovulation, age ≤38, and good previous endometrial receptivity.

When is it unsuitable: Patients with ovulation disorders, poor follicular development, or those needing to avoid a specific date for transfer.

III. Embryo Thawing: Key Details of the Laboratory Step

On the morning of the transfer day, embryology lab personnel retrieve the target embryo from the liquid nitrogen tank and operate according to the standard revival protocol. The thawing process takes about 2–3 hours, including: removing the embryo from the cryo-carrier, gradual rewarming, removing cryoprotectants, and assessing post-thaw embryo survival rate and morphological score.

What needs to be prepared: Patients do not need to make extra preparations for the thawing step but must arrive at the hospital on time on the morning of the transfer day to sign the informed consent form. The lab will confirm the embryo number, freezing date, and patient identification information in advance.

What are the risks: About 5%–10% of embryos may experience cell damage or decreased survival during thawing, especially for early-stage embryos where vitrification technology is not yet mature. Major reproductive centers in Kyrgyzstan now widely use vitrification, with revival survival rates consistently above 95%.

How to determine if an embryo is suitable for transfer: The lab considers an embryo viable if ≥50% of cells are intact after revival, but embryos with ≥70% intact cells are typically chosen for transfer. If embryo quality significantly declines after thawing, the doctor will discuss with the patient whether to cancel the current cycle transfer or use a backup embryo.

IV. Transfer Procedure: The Crucial 5–10 Minute Step

The transfer procedure is performed in an operating room under abdominal ultrasound guidance. The patient is placed in the lithotomy position. The doctor uses a speculum to expose the cervix, inserts a transfer catheter through the cervical canal into the uterine cavity, and slowly injects the embryo to a position about 1–1.5 cm from the uterine fundus. The entire process takes about 5–10 minutes, and most patients feel no pain or only mild distension.

What is the specific process?

• Preoperatively, the bladder should be moderately full to allow clear ultrasound visualization of the endometrial line;
• The doctor uses a transfer catheter (soft or rigid, depending on uterine position) to test the uterine cavity depth;
• The lab personnel hand the doctor the inner catheter loaded with the embryo;
• Under real-time ultrasound guidance, the catheter is placed at the predetermined position, and the embryo is slowly injected;
• After a 30-second pause, the catheter is withdrawn, and the lab checks for any embryo residue inside the catheter.

What should be noted? Before transfer, mechanical factors such as cervical adhesions or uterine fibroids compressing the cavity must be ruled out. If there is high resistance during transfer or a narrow cervical canal, the doctor may use a cervical dilator or switch to a rigid catheter. Absolute bed rest is not required after transfer, but strenuous activity is advised against on that day.

V. Post-Transfer Luteal Support: Continuing Until 10–12 Weeks of Pregnancy

Luteal support after transfer is crucial for maintaining endometrial receptivity. Exogenous progesterone supplementation is required regardless of whether HRT or a natural cycle was used. Common protocols include:

• Vaginal progesterone gel (Crinone): Once daily, convenient to use, stable absorption;
• Intramuscular progesterone injection: Once daily, high blood concentration, but requires assistance for injection;
• Oral dydrogesterone: Used as an adjunct, usually combined with other routes.

Luteal support starts on the day of transfer and continues until 10–12 weeks of pregnancy (i.e., after the placenta forms and takes over endocrine function). Do not stop medication without authorization during this period, as it could lead to endometrial shedding and miscarriage.

How long is it needed? If the pregnancy test is negative, menstruation will occur 2–5 days after stopping the medication. If the test is positive, medication continues until 10–12 weeks of pregnancy, after which the dosage is gradually reduced and stopped under medical guidance.

VI. Differentiated Strategies for Different Age Groups

Age is one of the most critical variables affecting transfer success rates. Reproductive centers in Kyrgyzstan make targeted adjustments when formulating transfer plans for different age groups:

Age Group	Endometrial Preparation Strategy	Number of Embryos Transferred	Special Points of Concern
≤35 years	Natural cycle or HRT acceptable	Single embryo transfer (preferred)	Reduce risk of multiple pregnancy
36–40 years	HRT protocol mostly	Single or double embryo (depending on embryo quality)	Enhanced endometrial monitoring, ERA testing if necessary
41–43 years	Primarily HRT protocol, consider adjuvant medication	Usually transfer 2 embryos	Genetic counseling, PGT-A screening (if applicable)
≥44 years	HRT protocol, emphasize endometrial receptivity assessment	2–3 embryos (according to regulations and medical indications)	Egg/embryo donation counseling (if repeated failure)

Why is age difference so important? With increasing age, the rate of oocyte aneuploidy rises, endometrial receptivity declines, and the immune-endocrine microenvironment changes. Therefore, older patients require more precise endometrial preparation and embryo selection strategies.

VII. Differences Between Kyrgyzstan and Other Countries

Compared with neighboring countries like Russia, Georgia, and Kazakhstan, the IVF transfer process in Kyrgyzstan has the following characteristics:

• Regulatory environment: Kyrgyzstan has more relaxed restrictions on the number of embryos transferred, allowing 1–3 embryos depending on patient age and embryo quality, but doctors prioritize recommending single embryo transfer to reduce multiple pregnancy risks;
• Medication availability: Some imported progesterone preparations (e.g., Crinone) need to be ordered in advance. A common local alternative is intramuscular progesterone injection, which is cheaper;
• Laboratory standards: Several major reproductive centers in Bishkek have ISO 15189 certification, and their embryo culture and freezing equipment are on par with mainstream European institutions;
• Patient process: International patients usually need to stay in Kyrgyzstan for at least 3–4 weeks (endometrial preparation + transfer + early pregnancy test). Some centers offer a collaborative model of remote monitoring + short-term stay.

How to choose: If a patient requires high medication convenience, it is recommended to choose a center well-stocked with imported medications. If the budget is limited, consider institutions primarily using intramuscular progesterone, but ensure the injection procedure is standardized.

VIII. Most Easily Overlooked Details and Common Misconceptions

In the transfer process, there are several easily overlooked aspects that can affect the outcome:

• Displaced endometrial receptivity window: About 15%–20% of patients have an endometrial receptivity window that does not align with the standard transfer time. For those with repeated implantation failure, an Endometrial Receptivity Array (ERA) test is recommended to determine the individualized transfer timing.
• Cervical mucus management: If cervical mucus is excessive or thick before transfer, it may hinder catheter passage or induce uterine contractions. The doctor will gently flush the cervical canal with saline before transfer.
• Constipation and diarrhea after transfer: Progesterone can inhibit intestinal motility, and combined with patient stress, can lead to bowel irregularities. A high-fiber diet is recommended after transfer, and mild laxatives like lactulose can be used if necessary.
• Neglecting thyroid function: Hypothyroidism or subclinical hypothyroidism can reduce endometrial receptivity. Ensure TSH is controlled to <2.5 mIU/L before transfer.

IX. Management of Special Situations

9.1 Thin Endometrium (<7mm)

For patients with a thin endometrium, the HRT protocol can involve increasing the estrogen dose or extending the medication duration, and if necessary, combining low-dose aspirin, Vitamin E, or intrauterine infusion of G-CSF. If the ideal thickness still cannot be achieved, consider accumulating embryos for a frozen cycle and performing a hysteroscopy to rule out intrauterine adhesions or endometrial polyps.

9.2 Repeated Implantation Failure (RIF)

For patients who have failed to implant after ≥3 transfers of good-quality embryos, it is recommended to sequentially investigate: embryo chromosomal abnormalities (PGT-A), endometrial receptivity window (ERA), chronic endometritis (CD138+ cell testing), and immune factors (NK cells, thyroid antibodies, etc.). In Kyrgyzstan, some centers have launched one-stop RIF etiology screening packages.

9.3 Hydrosalpinx

If ultrasound indicates hydrosalpinx, it is recommended to perform tubal embolization or ligation before transfer to prevent fluid from flowing back into the uterine cavity and affecting embryo implantation. This procedure can be done locally in Kyrgyzstan or handled in the home country before traveling to Kyrgyzstan for the transfer.

X. Required Tests Before Transfer

Before starting the transfer cycle, the following basic tests need to be completed (valid for 6–12 months, depending on the test):

• Female: Complete blood count, coagulation function, liver and kidney function, thyroid function, AMH, ultrasound (endometrium + ovaries + fallopian tubes), hysteroscopy (if necessary);
• Male: Semen analysis (for donor sperm cycles, infectious disease screening of the donor is required);
• Both partners: Infectious disease screening (Hepatitis B, Hepatitis C, HIV, Syphilis), chromosome karyotype analysis (for age ≥38 or recurrent miscarriage);
• Documents: Passport (valid for ≥6 months), marriage certificate (required in Kyrgyzstan), visa (medical visa allows a 30-day stay).

What should be noted? Some test results have an expiration date. For example, infectious disease screening is usually valid for 3–6 months, while chromosome karyotype is valid for life. It is recommended to complete all tests 1–2 months before departure and send the reports to the reproductive center for review in advance.

========== End: Risk Reminder ========== Bottom Identifier